DermTech (DMTK) Tops Q3 EPS by 19c

DermTech (NASDAQ: DMTK) reported Q3 EPS of ($0.57), $0.19 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c